HC Wainwright Analysts Raise Earnings Estimates for ARQT
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) – Research analysts at HC Wainwright raised their Q2 2025 earnings per share (EPS) estimates for shares of Arcutis Biotherapeutics in a report released on Wednesday, May 7th. HC Wainwright analyst D. Tsao now forecasts that the company will post earnings per share of ($0.20) for the quarter, […]
